BDBM50085037 6-Chloro-4-cyclopropyl-4-cyclopropylethynyl-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide::CHEMBL58552
SMILES: Clc1ccc2NS(=O)(=O)NC(C#CC3CC3)(C3CC3)c2c1
InChI Key: InChIKey=HPHZZAFKMHGJKQ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase (Human immunodeficiency virus 1) | BDBM50085037 (6-Chloro-4-cyclopropyl-4-cyclopropylethynyl-3,4-di...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.59E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description The compound was evaluated for the inhibition of HIV-1 reverse transcriptase | Bioorg Med Chem Lett 10: 193-5 (2000) BindingDB Entry DOI: 10.7270/Q21G0MSH | |||||||||||
More data for this Ligand-Target Pair |